The Effect of Radiation Treatment of Solid Tumors on Neutrophil Infiltration and Function: A Systematic Review.

Autor: Raymakers L; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Radiation Oncology, University Medical Center Utrecht, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Demmers TJ; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Meijer GJ; Department of Radiation Oncology, University Medical Center Utrecht, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Molenaar IQ; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St. Antonius Hospital Nieuwegein, Utrecht University, Utrecht, The Netherlands., van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St. Antonius Hospital Nieuwegein, Utrecht University, Utrecht, The Netherlands., Intven MPW; Department of Radiation Oncology, University Medical Center Utrecht, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Leusen JHW; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Olofsen PA; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Daamen LA; Department of Radiation Oncology, University Medical Center Utrecht, UMC Utrecht Cancer Center, Utrecht, The Netherlands; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St. Antonius Hospital Nieuwegein, Utrecht University, Utrecht, The Netherlands. Electronic address: l.a.daamen-3@umcutrecht.nl.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Nov 01; Vol. 120 (3), pp. 845-861. Date of Electronic Publication: 2024 Jul 14.

Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains.

Autor: Stip MC; Center for Translational Immunology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Jansen JHM; Center for Translational Immunology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Nederend M; Center for Translational Immunology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Tsioumpekou M; Center for Translational Immunology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Evers M; Center for Translational Immunology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Olofsen PA; Center for Translational Immunology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Meyer-Wentrup F; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands., Leusen JHW; Center for Translational Immunology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. j.h.w.leusen@umcutrecht.nl.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Sep; Vol. 72 (9), pp. 3063-3077. Date of Electronic Publication: 2023 Jun 20.

Truncated CSF3 receptors induce pro-inflammatory responses in severe congenital neutropenia.

Autor: Olofsen PA; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Bosch DA; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., de Looper HWJ; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., van Strien PMH; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Hoogenboezem RM; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Roovers O; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., van der Velden VHJ; Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Bindels EMJ; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., De Pater EM; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Touw IP; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.

Publikováno v: British journal of haematology [Br J Haematol] 2023 Jan; Vol. 200 (1), pp. 79-86. Date of Electronic Publication: 2022 Sep 28.

PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations.

Autor: Olofsen PA; Department of Hematology., Bosch DA; Department of Hematology., Roovers O; Department of Hematology., van Strien PMH; Department of Hematology., de Looper HWJ; Department of Hematology., Hoogenboezem RM; Department of Hematology., Barnhoorn S; Department of Molecular Genetics., Mastroberardino PG; Department of Molecular Genetics., Ghazvini M; Department of Developmental Biology, iPS Core Facility, and., van der Velden VHJ; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., Bindels EMJ; Department of Hematology., de Pater EM; Department of Hematology., Touw IP; Department of Hematology.

Publikováno v: Blood advances [Blood Adv] 2021 Feb 09; Vol. 5 (3), pp. 775-786.

Malignant Transformation Involving CXXC4 Mutations Identified in a Leukemic Progression Model of Severe Congenital Neutropenia.

Autor: Olofsen PA; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Fatrai S; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., van Strien PMH; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Obenauer JC; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., de Looper HWJ; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Hoogenboezem RM; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Erpelinck-Verschueren CAJ; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Vermeulen MPWM; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Roovers O; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Haferlach T; Munich Leukemia Laboratory (MLL), Munich 81377, Germany., Jansen JH; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands., Ghazvini M; Department of Developmental Biology, iPS Core Facility, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Bindels EMJ; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Schneider RK; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., de Pater EM; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands., Touw IP; Department of Hematology, Erasmus University Medical Center, Rotterdam 3015 CN, the Netherlands.

Publikováno v: Cell reports. Medicine [Cell Rep Med] 2020 Aug 25; Vol. 1 (5), pp. 100074. Date of Electronic Publication: 2020 Aug 25 (Print Publication: 2020).